Here we implemented in vitro model involving breast cancer cell lines (MDA-MB-231 and MCF-7) and healthy PBMC (Supplementary Figure S2; model justified by numerous studies [27,28] to reveal how blocking of CTLA-4 or PD-1 might contribute to anti-cancer effects, and whether its support initially presumed hypothesis. The gene discussed is CTLA4; the disease is breast cancer.